Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Scope of Consolidation - Additional Information (Details)

v3.24.0.1
Scope of Consolidation - Additional Information (Details) - EUR (€)
2 Months Ended 12 Months Ended
Dec. 31, 2023
Dec. 31, 2023
Dec. 31, 2022
Disclosure of subsidiaries [line items]      
Consideration adjustment parties within acquisition closing day   110 days  
Perugini S.r.l.      
Disclosure of subsidiaries [line items]      
Revenue € 54,300    
Profit € 900    
Medical Glass a.s.      
Disclosure of subsidiaries [line items]      
Percentage equity interest in subsidiary   99.74% 99.74%